Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies
Apply
Fostamatinib
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step